協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/26 | 2,918 | 2,969 | 2,915 | 2,958 | +40 | +1.4% | 649,800 |
2021/01/25 | 2,800 | 2,926 | 2,800 | 2,918 | +140 | +5% | 882,100 |
2021/01/22 | 2,789 | 2,791 | 2,752 | 2,778 | -48 | -1.7% | 457,800 |
2021/01/21 | 2,851 | 2,885 | 2,816 | 2,826 | -15 | -0.5% | 502,400 |
2021/01/20 | 2,859 | 2,859 | 2,827 | 2,841 | -15 | -0.5% | 560,300 |
2021/01/19 | 2,818 | 2,857 | 2,793 | 2,856 | +36 | +1.3% | 625,100 |
2021/01/18 | 2,837 | 2,853 | 2,814 | 2,820 | +2 | +0.1% | 477,800 |
2021/01/15 | 2,788 | 2,834 | 2,788 | 2,818 | +29 | +1% | 662,200 |
2021/01/14 | 2,767 | 2,822 | 2,755 | 2,789 | +28 | +1% | 675,500 |
2021/01/13 | 2,779 | 2,793 | 2,734 | 2,761 | -21 | -0.8% | 605,500 |
2021/01/12 | 2,813 | 2,818 | 2,744 | 2,782 | -53 | -1.9% | 923,300 |
2021/01/08 | 2,815 | 2,835 | 2,786 | 2,835 | +70 | +2.5% | 881,800 |
2021/01/07 | 2,770 | 2,780 | 2,748 | 2,765 | +45 | +1.7% | 655,500 |
2021/01/06 | 2,716 | 2,720 | 2,687 | 2,720 | -32 | -1.2% | 616,900 |
2021/01/05 | 2,811 | 2,820 | 2,739 | 2,752 | -33 | -1.2% | 496,900 |
2021/01/04 | 2,824 | 2,825 | 2,762 | 2,785 | -29 | -1% | 417,500 |
2020/12/30 | 2,826 | 2,843 | 2,808 | 2,814 | -18 | -0.6% | 657,200 |
2020/12/29 | 2,805 | 2,834 | 2,784 | 2,832 | +23 | +0.8% | 634,600 |
2020/12/28 | 2,793 | 2,836 | 2,780 | 2,809 | +66 | +2.4% | 716,800 |
2020/12/25 | 2,787 | 2,789 | 2,733 | 2,743 | -27 | -1% | 319,400 |
2020/12/24 | 2,754 | 2,776 | 2,735 | 2,770 | +7 | +0.3% | 473,100 |
2020/12/23 | 2,737 | 2,791 | 2,729 | 2,763 | +50 | +1.8% | 1,056,900 |
2020/12/22 | 2,683 | 2,725 | 2,680 | 2,713 | +27 | +1% | 713,400 |
2020/12/21 | 2,653 | 2,704 | 2,635 | 2,686 | +48 | +1.8% | 768,400 |
2020/12/18 | 2,645 | 2,652 | 2,623 | 2,638 | -11 | -0.4% | 1,424,400 |
2020/12/17 | 2,699 | 2,700 | 2,646 | 2,649 | -50 | -1.9% | 794,900 |
2020/12/16 | 2,740 | 2,754 | 2,675 | 2,699 | -35 | -1.3% | 845,500 |
2020/12/15 | 2,780 | 2,784 | 2,724 | 2,734 | -58 | -2.1% | 777,400 |
2020/12/14 | 2,827 | 2,845 | 2,789 | 2,792 | -51 | -1.8% | 842,000 |
2020/12/11 | 2,831 | 2,858 | 2,816 | 2,843 | +8 | +0.3% | 822,200 |
2020/12/10 | 2,831 | 2,844 | 2,820 | 2,835 | -15 | -0.5% | 404,500 |
2020/12/09 | 2,868 | 2,874 | 2,838 | 2,850 | -6 | -0.2% | 471,500 |
2020/12/08 | 2,882 | 2,882 | 2,840 | 2,856 | -33 | -1.1% | 504,300 |
2020/12/07 | 2,891 | 2,907 | 2,869 | 2,889 | +21 | +0.7% | 480,100 |
2020/12/04 | 2,849 | 2,888 | 2,844 | 2,868 | +2 | +0.1% | 506,700 |
2020/12/03 | 2,899 | 2,902 | 2,866 | 2,866 | -16 | -0.6% | 679,600 |
2020/12/02 | 2,895 | 2,904 | 2,853 | 2,882 | -7 | -0.2% | 699,400 |
2020/12/01 | 2,861 | 2,894 | 2,839 | 2,889 | +54 | +1.9% | 656,700 |
2020/11/30 | 2,901 | 2,916 | 2,803 | 2,835 | -45 | -1.6% | 1,769,100 |
2020/11/27 | 2,855 | 2,886 | 2,846 | 2,880 | +27 | +0.9% | 679,300 |
2020/11/26 | 2,815 | 2,860 | 2,792 | 2,853 | +45 | +1.6% | 591,200 |
2020/11/25 | 2,842 | 2,880 | 2,804 | 2,808 | -12 | -0.4% | 762,700 |
2020/11/24 | 2,781 | 2,827 | 2,761 | 2,820 | +72 | +2.6% | 846,900 |
2020/11/20 | 2,753 | 2,763 | 2,731 | 2,748 | -5 | -0.2% | 541,500 |
2020/11/19 | 2,772 | 2,776 | 2,729 | 2,753 | -47 | -1.7% | 959,300 |
2020/11/18 | 2,852 | 2,863 | 2,786 | 2,800 | -65 | -2.3% | 838,600 |
2020/11/17 | 2,897 | 2,897 | 2,849 | 2,865 | -47 | -1.6% | 842,000 |
2020/11/16 | 2,922 | 2,931 | 2,890 | 2,912 | -4 | -0.1% | 759,100 |
2020/11/13 | 2,939 | 2,953 | 2,903 | 2,916 | -34 | -1.2% | 1,039,700 |
2020/11/12 | 2,965 | 2,965 | 2,931 | 2,950 | +4 | +0.1% | 850,200 |
1051~
1100
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム